肝纤方联合西药治疗慢性乙型肝炎肝纤维化随机平行对照研究  被引量:1

Ganxian Soup combined with Western Medicine Treatment Chronic Hepatitis B Fibrosis Randomized Controlled Study

在线阅读下载全文

作  者:刘学强[1] 

机构地区:[1]河南省太康县人民医院内一科,河南太康461400

出  处:《实用中医内科杂志》2015年第10期112-114,共3页Journal of Practical Traditional Chinese Internal Medicine

摘  要:[目的]观察肝纤方联合西药治疗慢性乙型肝炎肝纤维化疗效。[方法]使用随机平行对照方法,将148例住院患者按掷骰子法简单随机分为两组。对照组74例复合维生素B,1片/次,3次/d;维生素C,0.1g/次,3次/d;肌苷,0.4g/次,3次/d;联苯双酯,7.5mg/次,3次/d;拉米夫丁,0.1g/次,1次/d。治疗组74例肝纤方(白花蛇舌草、半枝莲各30g,鳖甲、桃仁、当归、赤芍、海藻各20g,大黄制、水飞蓟、黄芪、丹参、鸡血藤各15g,生地、柴胡、甘草、三七粉各10g),1剂/d,水煎200m L,早晚分服,100m L/次;西药治疗同对照组。连续治疗1年为1疗程。观测临床症状、HA、P-CⅢ、Ⅳ-C、LN、不良反应。治疗1疗程,判定疗效。[结果]治疗组痊愈22例,显效25例,有效25例,无效2例,总有效率97.30%。对照组痊愈19例,显效24例,有效23例,无效8例,总有效率89.19%。治疗组疗效优于对照组(P<0.05)。肝纤维指标两组均有改善(P<0.01),治疗组改善优于对照组(P<0.01)。[结论]肝纤方联合西药治疗慢性乙型肝炎肝纤维化疗效满意,无严重不良反应,值得推广。[Objective]To observe Ganxian soup prescription combined with lamivudine in treating chronic hepatitis B fibrosis effect.[Methods]Randomized parallel controlled method,148 cases of hospitalized patients were randomly divided into two groups craps method is simple.The control group 74 cases of complex vitamins B,1/time,3 times/d.Vitamin C,0.1g/time,3 times/d.Inosine,0.4g/time,3 times/d.DDB,7.5mg/time,3 times/d.Lamivudine,0.1g/times,1 times/d.The treatment group 74 cases of liver fibrosis party(Baihuasheshecao,Banzhilian each 30 g,Biejia,Taoren,Dangui,Chishao,Haizao 20 g,Dahung,Shuifeiji,Huangqi,D anshen,Jixueteng 15 g,Shengdi,Chaihu,Gancao,Sanqifen each 10g),1/d,decoction 200 m L,morning and evening hours,100 m L/times.Western medicine with the control group.Continuous treatment for one year for a course.Observation of clinical symptoms,HA,P-CⅢ,Ⅳ-C,LN,adverse reactions.One course of treatment,to determine efficacy.[Results]The cure 22 cases,25 cases markedly effective in 25 cases,2 cases,the total efficiency of 97.30%.Cured 19 cases in the control group,24 cases markedly effective in 23 cases,8 cases,the total efficiency of 89.19%.Treatment group than the control group(P〈0.05).Hepatic fibrosis indicators improved in both groups(P〈0.01),the treatment group than the control group improved(P〈0.01).[Conclusion]Ganxian soup combined lamivudine treatment of chronic hepatitis B fibrosis results were satisfactory,no serious adverse reactions,it is worth promoting.

关 键 词:慢性乙型肝炎肝纤维化 癥积 肝纤方 复合维生素B 维生素C 肌苷 联苯双酯 拉米夫丁 HA P-CⅢ Ⅳ-C LN 中西医结合治疗 随机平行对照研究 

分 类 号:R512.62[医药卫生—内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象